| 臺大學術典藏 |
2021-12-14T23:12:13Z |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, Caroline; Wang, Hung Ming; Li, Shau Hsuan; Ngan, Roger K.C.; Dechaphunkul, Arunee; Zhang, Li; Yen, Chia Jui; Chan, Po Chung; Chakrabandhu, Somvilai; Ma, Brigette B.Y.; Tanasanvimon, Suebpong; Lee, Victor H.F.; PEI-JEN LOU; Li, Zujun; Spira, Alexander I.; Sukari, Ammar; Guigay, Jo€el; McCune, Steven; Gonzalez-Maffe, Juan; Szpakowski, Sebastian; Yao, Yao; Liang, Hongzi; Mataraza, Jennifer; Sechaud, Romain; Manenti, Luigi; Lim, Darren W.T. |
